BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
580306	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2cc(ccc12)N(CC(=O)N1C[C@H](F)C[C@H]1C(=O)NCc1cccc(Cl)c1F)S(C)(=O)=O |r,$;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;HN;;;;;;;;;;;;;$|	InChI=1S/C39H38Cl2F4N6O7S/c1-21(52)28-18-48(19-34(53)49-16-24(42)11-32(49)38(55)46-14-22-5-3-7-29(40)36(22)44)31-13-26(9-10-27(28)31)51(59(2,57)58)20-35(54)50-17-25(43)12-33(50)39(56)47-15-23-6-4-8-30(41)37(23)45/h3-10,13,18,24-25,32-33H,11-12,14-17,19-20H2,1-2H3,(H,46,55)(H,47,56)	ITRSBQLGALZVHQ-UHFFFAOYSA-N	302863	(2S,4R)-1-(2-(N-(3- acetyl-1-(2-((2S,4R)- 2-(3-chloro-2- fluorobenzyl- carbamoyl)- 4-fluoropyrrolidin- 1-yl)-2-oxoethyl)-1H- indol-6- yl)methylsulfonamido) acetyl)-N-(3-chloro- 2-fluorobenzyl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 1::US10660876, Cmpd No. 1	Complement factor D	Human		 5500							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302863	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302863&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118335795	381751598							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580307	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2cc(NS(=O)(=O)C(F)(F)F)ccc12 |r,$;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;HN;;;;;;;;;;$|	InChI=1S/C25H22ClF5N4O5S/c1-13(36)18-11-34(20-8-16(5-6-17(18)20)33-41(39,40)25(29,30)31)12-22(37)35-10-15(27)7-21(35)24(38)32-9-14-3-2-4-19(26)23(14)28/h2-6,8,11,15,21,33H,7,9-10,12H2,1H3,(H,32,38)	SQTJLNWMLDJDNK-UHFFFAOYSA-N	302867	(2S,4R)-1-(2-(3- acetyl-6- (trifluoromethylsulfon- amido)-1H-indol-1- yl)acetyl)-N-(3- chloro-2- fluorobenzyl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 2::US10660876, Cmpd No. 2	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302867	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302867&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			91844727	381751602							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580308	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C33H27ClF2N6O3/c1-19(43)26-16-41(29-10-9-21(12-25(26)29)39-22-13-37-18-38-14-22)17-31(44)42-15-20(35)11-30(42)33(45)40-28-8-4-6-24(32(28)36)23-5-2-3-7-27(23)34/h2-10,12-14,16,18,20,30,39H,11,15,17H2,1H3,(H,40,45)	RKJKLXSEXCNGRV-UHFFFAOYSA-N	302872	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US9598446, Compound 3::US10660876, Cmpd No. 3	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302872	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302872&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322544	381751607							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580309	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C26H23BrFN7O3/c1-15(36)20-12-34(21-6-5-17(8-19(20)21)31-18-9-29-14-30-10-18)13-25(37)35-11-16(28)7-22(35)26(38)33-24-4-2-3-23(27)32-24/h2-6,8-10,12,14,16,22,31H,7,11,13H2,1H3,(H,32,33,38)	HMMRVXSBYXZXKG-UHFFFAOYSA-N	302874	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 4::US10660876, Cmpd No. 6	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302874	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302874&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322556	381751609							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580310	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(Nc3cncc(F)c3)cc12 |r|	InChI=1S/C27H23BrF2N6O3/c1-15(37)21-13-35(22-6-5-18(9-20(21)22)32-19-7-16(29)10-31-11-19)14-26(38)36-12-17(30)8-23(36)27(39)34-25-4-2-3-24(28)33-25/h2-7,9-11,13,17,23,32H,8,12,14H2,1H3,(H,33,34,39)	AFQUAFCJWNUTTL-UHFFFAOYSA-N	302878	(2S,4R)-1-(2-(3- acetyl-5-(5- fluoropyridin-3- ylamino)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 5::US10660876, Cmpd No. 5	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302878	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302878&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322549	381751613							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580311	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)n2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C26H23ClFN7O3/c1-15(36)20-12-34(21-6-5-17(8-19(20)21)31-18-9-29-14-30-10-18)13-25(37)35-11-16(28)7-22(35)26(38)33-24-4-2-3-23(27)32-24/h2-6,8-10,12,14,16,22,31H,7,11,13H2,1H3,(H,32,33,38)	GJTBGVQZGHAMCE-UHFFFAOYSA-N	302879	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(6- chloropyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 6	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302879	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302879&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322517	381751614							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580312	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@H](CO)c2cccc(Cl)c2F)c2ccc(Nc3cncnc3)cc12 |r,$;;;;;;;;;;;;;;;;;HN;;;;;;;;;;;;;;;;;;;;;;;;$|	InChI=1S/C29H27ClF2N6O4/c1-16(40)22-12-37(25-6-5-18(8-21(22)25)35-19-9-33-15-34-10-19)13-27(41)38-11-17(31)7-26(38)29(42)36-24(14-39)20-3-2-4-23(30)28(20)32/h2-6,8-10,12,15,17,24,26,35,39H,7,11,13-14H2,1H3,(H,36,42)	ZYGIDXYHEYEFFB-UHFFFAOYSA-N	302880	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-((S)-1- (3-chloro-2- fluorophenyl)-2- hydroxyethyl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 7::US10660876, Cmpd No. 7	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302880	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302880&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322641	381751615							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580313	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@@H](CO)c2cccc(Cl)c2F)c2ccc(Nc3cncnc3)cc12 |r,$;;;;;;;;;;;;;;;;;HN;;;;;;;;;;;;;;;;;;;;;;;;$|	InChI=1S/C29H27ClF2N6O4/c1-16(40)22-12-37(25-6-5-18(8-21(22)25)35-19-9-33-15-34-10-19)13-27(41)38-11-17(31)7-26(38)29(42)36-24(14-39)20-3-2-4-23(30)28(20)32/h2-6,8-10,12,15,17,24,26,35,39H,7,11,13-14H2,1H3,(H,36,42)	ZYGIDXYHEYEFFB-UHFFFAOYSA-N	302881	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-((R)-1- (3-chloro-2- fluorophenyl)-2- hydroxyethyl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 8::US10660876, Cmpd No. 8	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302881	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302881&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322508	381751616							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580314	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(Nc3cccnn3)cc12 |r|	InChI=1S/C31H25ClF2N8O3/c32-22-7-2-1-5-19(22)20-6-3-8-23(28(20)34)38-31(45)25-13-17(33)15-41(25)27(43)16-42-24-11-10-18(37-26-9-4-12-36-39-26)14-21(24)29(40-42)30(35)44/h1-12,14,17,25H,13,15-16H2,(H2,35,44)(H,37,39)(H,38,45)	IXPCCHVYUPSKBE-UHFFFAOYSA-N	302882	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-3- ylamino)-1H- indazole-3- carboxamide::US9598446, Compound 9::US10660876, Cmpd No. 9	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302882	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302882&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322584	381751617							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580315	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C31H25ClF2N8O3/c32-23-6-2-1-4-20(23)21-5-3-7-24(28(21)34)39-31(45)26-10-17(33)14-41(26)27(43)15-42-25-9-8-18(38-19-12-36-16-37-13-19)11-22(25)29(40-42)30(35)44/h1-9,11-13,16-17,26,38H,10,14-15H2,(H2,35,44)(H,39,45)	KVEHFCYWAHYLOA-UHFFFAOYSA-N	302883	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyrimidin-5- ylamino)-1H- indazole-3- carboxamide::US9598446, Compound 10::US10660876, Cmpd No. 10	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302883	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302883&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322510	381751618							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580316	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)n2)c2ccc(Nc3cccnn3)cc12 |r|	InChI=1S/C24H21ClFN9O3/c25-18-3-1-4-19(30-18)31-24(38)17-9-13(26)11-34(17)21(36)12-35-16-7-6-14(29-20-5-2-8-28-32-20)10-15(16)22(33-35)23(27)37/h1-8,10,13,17H,9,11-12H2,(H2,27,37)(H,29,32)(H,30,31,38)	YLJHRWJEVZGUAX-UHFFFAOYSA-N	302884	1-(2-((2S,4R)-2-(6- chloropyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-3- ylamino)-1H- indazole-3- carboxamide::US9598446, Compound 11	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302884	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302884&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322625	381751619							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580317	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)n2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C24H21ClFN9O3/c25-19-2-1-3-20(31-19)32-24(38)18-6-13(26)10-34(18)21(36)11-35-17-5-4-14(30-15-8-28-12-29-9-15)7-16(17)22(33-35)23(27)37/h1-5,7-9,12-13,18,30H,6,10-11H2,(H2,27,37)(H,31,32,38)	HYNKZTKMOWBTPY-UHFFFAOYSA-N	302889	1-(2-((2S,4R)-2-(6- chloropyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyrimidin-5- ylamino)-1H- indazole-3- carboxamide::US9598446, Compound 12::US10660876, Cmpd No. 12	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302889	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302889&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322509	381751624							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580318	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(Nc3ncc(cn3)C#N)cc12 |r|	InChI=1S/C32H24ClF2N9O3/c33-23-6-2-1-4-20(23)21-5-3-7-24(28(21)35)41-31(47)26-10-18(34)15-43(26)27(45)16-44-25-9-8-19(11-22(25)29(42-44)30(37)46)40-32-38-13-17(12-36)14-39-32/h1-9,11,13-14,18,26H,10,15-16H2,(H2,37,46)(H,41,47)(H,38,39,40)	MUAYRPVDPJBKCK-UHFFFAOYSA-N	302893	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(5- cyanopyrimidin-2- ylamino)-1H- indazole-3- carboxamide::US9598446, Compound 13::US10660876, Cmpd No. 13	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302893	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302893&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322516	381751628							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580319	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(Nc3cnc(nc3)C(F)(F)F)cc12 |r|	InChI=1S/C32H24ClF5N8O3/c33-22-6-2-1-4-19(22)20-5-3-7-23(27(20)35)43-30(49)25-10-16(34)14-45(25)26(47)15-46-24-9-8-17(11-21(24)28(44-46)29(39)48)42-18-12-40-31(41-13-18)32(36,37)38/h1-9,11-13,16,25,42H,10,14-15H2,(H2,39,48)(H,43,49)	XXYOBMWPJFTCBD-UHFFFAOYSA-N	302900	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(2- (trifluoromethyl) pyrimidin- 5-ylamino)-1H- indazole-3- carboxamide::US9598446, Compound 14::US10660876, Cmpd No. 14	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302900	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302900&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322539	381751635							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580320	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)N(COC(=O)C(C)(C)C)c1cncnc1 |r|	InChI=1S/C39H37ClF2N6O5/c1-23(49)30-19-46(33-13-12-25(15-29(30)33)48(26-16-43-21-44-17-26)22-53-38(52)39(2,3)4)20-35(50)47-18-24(41)14-34(47)37(51)45-32-11-7-9-28(36(32)42)27-8-5-6-10-31(27)40/h5-13,15-17,19,21,24,34H,14,18,20,22H2,1-4H3,(H,45,51)	GNZMPALPIWBMBP-UHFFFAOYSA-N	302902	((3-acetyl-1-(2- ((2S,4R)-2-(2'-chloro- 2-fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-1H-indol- 5-yl)(pyrimidin-5- yl)amino)methylpivalate::US9598446, Compound 15::US10660876, Cmpd No. 15	Complement factor D	Human		 5500							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302902	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302902&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322559	381751637							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580321	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2nc3ccccc3s2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C29H26FN7O3S/c1-17(38)22-14-36(24-7-6-19(9-21(22)24)34-20-10-31-16-32-11-20)15-28(39)37-13-18(30)8-25(37)29(40)33-12-27-35-23-4-2-3-5-26(23)41-27/h2-7,9-11,14,16,18,25,34H,8,12-13,15H2,1H3,(H,33,40)	SOYGBVIMKRVTTR-UHFFFAOYSA-N	302903	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol- yl)acetyl)-N- (benzo[d]thiazol-2- ylmethyl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 16::US10660876, Cmpd No. 16	Complement factor D	Human		 5500							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302903	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302903&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322541	381751638							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580322	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2ccccn2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C27H26FN7O3/c1-17(36)23-14-34(24-6-5-19(9-22(23)24)33-21-10-29-16-30-11-21)15-26(37)35-13-18(28)8-25(35)27(38)32-12-20-4-2-3-7-31-20/h2-7,9-11,14,16,18,25,33H,8,12-13,15H2,1H3,(H,32,38)	YDUVJFMYAWLJIK-UHFFFAOYSA-N	302928	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (pyridin-2- ylmethyl)pyrrolidine- 2-carboxamide::US9598446, Compound 17::US10660876, Cmpd No. 17	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302928	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302928&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322646	381751663							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580323	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cc(F)cc(Cl)c2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C28H25ClF2N6O3/c1-16(38)24-13-36(25-3-2-21(8-23(24)25)35-22-10-32-15-33-11-22)14-27(39)37-12-20(31)7-26(37)28(40)34-9-17-4-18(29)6-19(30)5-17/h2-6,8,10-11,13,15,20,26,35H,7,9,12,14H2,1H3,(H,34,40)	WVOBBOGINQAHSV-UHFFFAOYSA-N	302930	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(3- chloro-5- fluorobenzyl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 18::US10660876, Cmpd No. 18	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302930	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302930&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322582	381751665							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580324	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccc(Cl)c2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C28H26ClFN6O3/c1-17(37)24-14-35(25-6-5-21(9-23(24)25)34-22-11-31-16-32-12-22)15-27(38)36-13-20(30)8-26(36)28(39)33-10-18-3-2-4-19(29)7-18/h2-7,9,11-12,14,16,20,26,34H,8,10,13,15H2,1H3,(H,33,39)	YYNKXNFVLQYOKI-UHFFFAOYSA-N	302931	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(3- chlorobenzyl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 19::US10660876, Cmpd No. 19	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302931	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302931&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322553	381751666							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580325	CNC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1cc(C(C)=O)c2cc(Nc3cncnc3)ccc12 |r|	InChI=1S/C22H23FN6O3/c1-13(30)18-10-28(11-21(31)29-9-14(23)5-20(29)22(32)24-2)19-4-3-15(6-17(18)19)27-16-7-25-12-26-8-16/h3-4,6-8,10,12,14,20,27H,5,9,11H2,1-2H3,(H,24,32)	LKCHOVQRWROKNT-UHFFFAOYSA-N	302945	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- methylpyrrolidine-2- carboxamide::US9598446, Compound 20::US10660876, Cmpd No. 20	Complement factor D	Human		 5500							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302945	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302945&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322557	381751680							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580326	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)c2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C26H23BrFN7O3/c1-15(36)22-12-34(23-3-2-18(6-21(22)23)32-20-9-30-14-31-10-20)13-25(37)35-11-17(28)5-24(35)26(38)33-19-4-16(27)7-29-8-19/h2-4,6-10,12,14,17,24,32H,5,11,13H2,1H3,(H,33,38)	KCCSOWPTTFVCBI-UHFFFAOYSA-N	303009	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(5- bromopyridin-3-yl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 21::US10660876, Cmpd No. 21	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303009	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303009&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322562	381751744							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580327	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Cl)c2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C26H23ClFN7O3/c1-15(36)22-12-34(23-3-2-18(6-21(22)23)32-20-9-30-14-31-10-20)13-25(37)35-11-17(28)5-24(35)26(38)33-19-4-16(27)7-29-8-19/h2-4,6-10,12,14,17,24,32H,5,11,13H2,1H3,(H,33,38)	HBJCDWDKJMRYCW-UHFFFAOYSA-N	303010	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(5- chloropyridin-3-yl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 22::US10660876, Cmpd No. 22	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303010	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303010&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322555	381751745							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580328	CCN1Cc2ccc(NC(=O)[C@@H]3C[C@@H](F)CN3C(=O)Cn3cc(C(C)=O)c4cc(Nc5cncnc5)ccc34)cc2C1=O |r|	InChI=1S/C31H30FN7O4/c1-3-37-13-19-4-5-22(9-24(19)31(37)43)36-30(42)28-8-20(32)14-39(28)29(41)16-38-15-26(18(2)40)25-10-21(6-7-27(25)38)35-23-11-33-17-34-12-23/h4-7,9-12,15,17,20,28,35H,3,8,13-14,16H2,1-2H3,(H,36,42)	ATPSKHFIIPPEIS-UHFFFAOYSA-N	303011	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(2-ethyl- 3-oxoisoindolin-5-yl)- 4-fluoropyrrolidine-2- carboxamide::US9598446, Compound 23::US10660876, Cmpd No. 23	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303011	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303011&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322637	381751746							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580329	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc3CC(C)(C)Oc23)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C31H31FN6O4/c1-18(39)24-15-37(26-8-7-21(10-23(24)26)35-22-12-33-17-34-13-22)16-28(40)38-14-20(32)9-27(38)30(41)36-25-6-4-5-19-11-31(2,3)42-29(19)25/h4-8,10,12-13,15,17,20,27,35H,9,11,14,16H2,1-3H3,(H,36,41)	WZHHICLBIJGXRJ-UHFFFAOYSA-N	303012	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(2,2- dimethyl-2,3- dihydrobenzofuran-7- yl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 24::US10660876, Cmpd No. 24	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303012	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303012&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322573	381751747							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580330	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3cn[nH]c3c2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C28H25FN8O3/c1-16(38)23-13-36(25-5-4-19(7-22(23)25)33-21-10-30-15-31-11-21)14-27(39)37-12-18(29)6-26(37)28(40)34-20-3-2-17-9-32-35-24(17)8-20/h2-5,7-11,13,15,18,26,33H,6,12,14H2,1H3,(H,32,35)(H,34,40)	DRBXELYKTAATCH-UHFFFAOYSA-N	303013	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (1H-indazol-6- yl)pyrrolidine-2- carboxamide::US9598446, Compound 25::US10660876, Cmpd No. 25	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303013	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303013&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322554	381751748							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580331	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(F)c(c2)-c2nnc3CCCCCn23)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C34H33F2N9O3/c1-20(46)27-17-43(29-9-7-22(12-25(27)29)39-24-14-37-19-38-15-24)18-32(47)45-16-21(35)11-30(45)34(48)40-23-6-8-28(36)26(13-23)33-42-41-31-5-3-2-4-10-44(31)33/h6-9,12-15,17,19,21,30,39H,2-5,10-11,16,18H2,1H3,(H,40,48)	UFEWSPZTKCPRSJ-UHFFFAOYSA-N	303015	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (4-fluoro-3-(6,7,8,9- tetrahydro-5H- [1,2,4]triazolo[4,3- a]azepin-3- yl)phenyl)pyrrolidine- 2-carboxamide::US9598446, Compound 26::US10660876, Cmpd No. 26	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303015	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303015&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322545	381751750							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580332	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Cc2cccc3CN(Cc23)c2ccccn2)c2ccc(Nc3cncnc3)cc12 |r,$;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;HN;;;;;;;;$|	InChI=1S/C35H32FN7O3/c1-22(44)29-18-41(31-9-8-26(13-28(29)31)40-27-14-37-21-38-15-27)20-35(46)43-17-25(36)12-32(43)33(45)11-23-5-4-6-24-16-42(19-30(23)24)34-7-2-3-10-39-34/h2-10,13-15,18,21,25,32,40H,11-12,16-17,19-20H2,1H3	HIKAVSNRDVUNRI-UHFFFAOYSA-N	303016	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (2-(pyridin-2- yl)isoindolin-4- yl)pyrrolidine-2- carboxamide::US9598446, Compound 27	Complement factor D	Human		 5500							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303016	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303016&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118335890	381751751							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580333	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCCc3nc(sc23)-c2ccc(F)cc2)c2ccc(Nc3cncnc3)cc12 |r,$;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;HN;;;;;;;;$|	InChI=1S/C34H31F2N7O3S/c1-19(44)26-16-42(29-10-9-23(12-25(26)29)39-24-13-37-18-38-14-24)17-31(45)43-15-22(36)11-30(43)33(46)40-27-3-2-4-28-32(27)47-34(41-28)20-5-7-21(35)8-6-20/h5-10,12-14,16,18,22,27,30,39H,2-4,11,15,17H2,1H3,(H,40,46)	VZFSQLHHDAVXMK-UHFFFAOYSA-N	303023	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (2-(4-fluorophenyl)- 4,5,6,7- tetrahydrobenzo[d] thiazol- 7-yl)pyrrolidine- 2-carboxamide::US9598446, Compound 28::US10660876, Cmpd No. 28	Complement factor D	Human		>10000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303023	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303023&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322629	381751758							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580334	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(ns2)-c2ccccc2Cl)c2ccc(Nc3cncnc3)cc12 |r,$;;;;;;;;;;;;;;;;;HN;;;;;;;;;;;;;;;;;;;;;;;;;$|	InChI=1S/C29H24ClFN8O3S/c1-16(40)22-13-38(24-7-6-18(9-21(22)24)34-19-10-32-15-33-11-19)14-26(41)39-12-17(31)8-25(39)28(42)36-29-35-27(37-43-29)20-4-2-3-5-23(20)30/h2-7,9-11,13,15,17,25,34H,8,12,14H2,1H3,(H,35,36,37,42)	TVYTXIFEGGLDBX-UHFFFAOYSA-N	303024	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(3-(2- chlorophenyl)-1,2,4- thiadiazol-5-yl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 29::US10660876, Cmpd No. 29	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303024	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303024&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322535	381751759							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580335	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccccc2-n2nccc2C)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C31H29FN8O3/c1-19-9-10-35-40(19)28-6-4-3-5-26(28)37-31(43)29-11-21(32)15-39(29)30(42)17-38-16-25(20(2)41)24-12-22(7-8-27(24)38)36-23-13-33-18-34-14-23/h3-10,12-14,16,18,21,29,36H,11,15,17H2,1-2H3,(H,37,43)	FNXTWAABCNBCFJ-UHFFFAOYSA-N	303025	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (2-(5-methyl-1H- pyrazol-1- yl)phenyl)pyrrolidine- 2-carboxamide::US9598446, Compound 30::US10660876, Cmpd No. 30	Complement factor D	Human		 5500							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303025	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303025&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322507	381751760							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580336	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccnc2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C26H24FN7O3/c1-16(35)22-13-33(23-5-4-18(8-21(22)23)31-20-10-29-15-30-11-20)14-25(36)34-12-17(27)7-24(34)26(37)32-19-3-2-6-28-9-19/h2-6,8-11,13,15,17,24,31H,7,12,14H2,1H3,(H,32,37)	LYFPJRNZTADLAU-UHFFFAOYSA-N	303026	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (pyridin-3- yl)pyrrolidine-2- carboxamide::US9598446, Compound 31::US10660876, Cmpd No. 31	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303026	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303026&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322568	381751761							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580337	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccccc2-c2nc3ccccc3s2)c2ccc(Nc3cncnc3)cc12 |r,$;;;;;;;;;;;;;;;;;HN;;;;;;;;;;;;;;;;;;;;HN;;;;;;;;$|	InChI=1S/C34H28FN7O3S/c1-20(43)26-17-41(29-11-10-22(13-25(26)29)38-23-14-36-19-37-15-23)18-32(44)42-16-21(35)12-30(42)33(45)39-27-7-3-2-6-24(27)34-40-28-8-4-5-9-31(28)46-34/h2-11,13-15,17,19,21,30,38H,12,16,18H2,1H3,(H,39,45)	MXDAZWOBUOVFGF-UHFFFAOYSA-N	303027	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(2- (benzo[d]thiazol-2- yl)phenyl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 32::US10660876, Cmpd No. 32	Complement factor D	Human		>10000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303027	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303027&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322580	381751762							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580338	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Cl)n2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C25H22ClFN8O3/c1-14(36)19-11-34(20-3-2-16(5-18(19)20)31-17-6-29-13-30-7-17)12-24(37)35-10-15(27)4-21(35)25(38)33-23-9-28-8-22(26)32-23/h2-3,5-9,11,13,15,21,31H,4,10,12H2,1H3,(H,32,33,38)	BDZIORIMTVSHFW-UHFFFAOYSA-N	303028	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(6- chloropyrazin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 33::US10660876, Cmpd No. 33	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303028	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303028&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322560	381751763							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580339	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nnc(s2)-c2ccccc2Cl)c2ccc(Nc3cncnc3)cc12 |r,$;;;;;;;;;;;;;;;;;HN;;;;;;;;;;;;;;;;;;;;;;;;;$|	InChI=1S/C29H24ClFN8O3S/c1-16(40)22-13-38(24-7-6-18(9-21(22)24)34-19-10-32-15-33-11-19)14-26(41)39-12-17(31)8-25(39)27(42)35-29-37-36-28(43-29)20-4-2-3-5-23(20)30/h2-7,9-11,13,15,17,25,34H,8,12,14H2,1H3,(H,35,37,42)	AUXLDALGRIJXBH-UHFFFAOYSA-N	303029	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(5-(2- chlorophenyl)-1,3,4- thiadiazol-2-yl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 34::US10660876, Cmpd No. 34	Complement factor D	Human		 5500							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303029	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303029&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322570	381751764							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580340	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc3OC(F)(F)Oc3cc2F)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C28H22F4N6O5/c1-14(39)19-11-37(22-3-2-16(5-18(19)22)35-17-8-33-13-34-9-17)12-26(40)38-10-15(29)4-23(38)27(41)36-21-7-25-24(6-20(21)30)42-28(31,32)43-25/h2-3,5-9,11,13,15,23,35H,4,10,12H2,1H3,(H,36,41)	PEVSBOFMPAVDJO-UHFFFAOYSA-N	303030	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (2,2,6- trifluorobenzo[d][1,3] dioxol-5- yl)pyrrolidine-2- carboxamide::US9598446, Compound 35::US10660876, Cmpd No. 35	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303030	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303030&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322537	381751765							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580341	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@H]2CCCC[C@@H]2O)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C27H31FN6O4/c1-16(35)21-13-33(23-7-6-18(9-20(21)23)31-19-10-29-15-30-11-19)14-26(37)34-12-17(28)8-24(34)27(38)32-22-4-2-3-5-25(22)36/h6-7,9-11,13,15,17,22,24-25,31,36H,2-5,8,12,14H2,1H3,(H,32,38)	FQSQPAAVOVUZKG-UHFFFAOYSA-N	303031	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- ((1S,2S)-2- hydroxycyclohexyl)pyr- rolidine-2-carboxamide::US9598446, Compound 36::US10660876, Cmpd No. 36	Complement factor D	Human		 5500							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303031	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303031&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322585	381751766							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580342	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)c2-n2cncn2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C29H25ClFN9O3/c1-17(41)22-12-38(25-6-5-19(8-21(22)25)36-20-9-32-14-33-10-20)13-27(42)39-11-18(31)7-26(39)29(43)37-24-4-2-3-23(30)28(24)40-16-34-15-35-40/h2-6,8-10,12,14-16,18,26,36H,7,11,13H2,1H3,(H,37,43)	FBLSRJSPKFKYBV-UHFFFAOYSA-N	303032	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(3- chloro-2-(1H-1,2,4- triazol-1-yl)phenyl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 37::US10660876, Cmpd No. 37	Complement factor D	Human		 5500							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303032	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303032&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322626	381751767							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580343	CC(=O)c1cn(CC(=O)C2C[C@H](F)C[C@H]2C(=O)Nc2ccc3[nH]c(C)c(C)c3c2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C32H31FN6O3/c1-17-18(2)36-29-6-4-22(10-24(17)29)38-32(42)27-9-20(33)8-26(27)31(41)15-39-14-28(19(3)40)25-11-21(5-7-30(25)39)37-23-12-34-16-35-13-23/h4-7,10-14,16,20,26-27,36-37H,8-9,15H2,1-3H3,(H,38,42)	XPFBDZNZQHKYCE-UHFFFAOYSA-N	303033	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(2,3- dimethyl-1H-indol-5- yl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 38	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303033	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303033&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118333556	381751768							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580344	CC(=O)c1cn(C(=O)CN2C[C@H](F)C[C@H]2C(=O)Nc2nnc(s2)-c2ccc(Cl)c(Cl)c2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C29H23Cl2FN8O3S/c1-15(41)21-12-40(24-5-3-18(8-20(21)24)35-19-9-33-14-34-10-19)26(42)13-39-11-17(32)7-25(39)27(43)36-29-38-37-28(44-29)16-2-4-22(30)23(31)6-16/h2-6,8-10,12,14,17,25,35H,7,11,13H2,1H3,(H,36,38,43)	SMTUMKLDXICUHQ-UHFFFAOYSA-N	303034	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)-2-oxoethyl)-N-(5- (3,4-dichlorophenyl)- 1,3,4-thiadiazol-2-yl)- 4-fluoropyrrolidine-2- carboxamide::US9598446, Compound 39::US10660876, Cmpd No. 39	Complement factor D	Human		>10000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303034	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303034&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322566	381751769							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580345	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccccc2N2CCOC2=O)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C30H28FN7O5/c1-18(39)23-15-36(25-7-6-20(11-22(23)25)34-21-12-32-17-33-13-21)16-28(40)38-14-19(31)10-27(38)29(41)35-24-4-2-3-5-26(24)37-8-9-43-30(37)42/h2-7,11-13,15,17,19,27,34H,8-10,14,16H2,1H3,(H,35,41)	JHRXGDFDOKCUTP-UHFFFAOYSA-N	303035	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (2-(2-oxooxazolidin- 3- yl)phenyl)pyrrolidine- 2-carboxamide::US9598446, Compound 40::US10660876, Cmpd No. 40	Complement factor D	Human		 5500							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303035	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303035&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322533	381751770							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580346	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(C)nc3nc(nn23)C(F)(F)F)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C28H24F4N10O3/c1-14-5-23(42-27(35-14)38-26(39-42)28(30,31)32)37-25(45)22-6-16(29)10-41(22)24(44)12-40-11-20(15(2)43)19-7-17(3-4-21(19)40)36-18-8-33-13-34-9-18/h3-5,7-9,11,13,16,22,36H,6,10,12H2,1-2H3,(H,37,45)	YADGHFCERYVAGX-UHFFFAOYSA-N	303036	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (5-methyl-2- (trifluoromethyl)- [1,2,4]triazolo[1,5- a]pyrimidin-7- yl)pyrrolidine-2- carboxamide::US9598446, Compound 41::US10660876, Cmpd No. 41	Complement factor D	Human		>10000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303036	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303036&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322561	381751771							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580347	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCCN(C2)c2cnn(C)c2)c2ccc(Nc3cncnc3)cc12 |r,$;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;HN;;;;;;;;$|	InChI=1S/C30H34FN9O3/c1-19(41)26-16-39(27-6-5-21(9-25(26)27)35-23-10-32-18-33-11-23)17-29(42)40-13-20(31)8-28(40)30(43)36-22-4-3-7-38(14-22)24-12-34-37(2)15-24/h5-6,9-12,15-16,18,20,22,28,35H,3-4,7-8,13-14,17H2,1-2H3,(H,36,43)	MWQHZUNYDRLVBN-UHFFFAOYSA-N	303037	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (1-(1-methyl-1H- pyrazol-4- yl)piperidin-3- yl)pyrrolidine-2- carboxamide::US9598446, Compound 42::US10660876, Cmpd No. 42	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303037	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303037&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322511	381751772							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580348	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccnc2)c2ccc(Nc3cncnc3)cc12 |r,$;;;;;;;;;;;;;;;;;;;;;;;;;;;;;HN;;;;;;;;$|	InChI=1S/C27H26FN7O3/c1-17(36)23-14-34(24-5-4-20(8-22(23)24)33-21-11-30-16-31-12-21)15-26(37)35-13-19(28)7-25(35)27(38)32-10-18-3-2-6-29-9-18/h2-6,8-9,11-12,14,16,19,25,33H,7,10,13,15H2,1H3,(H,32,38)	BFIHQPVUURUCOH-UHFFFAOYSA-N	303038	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (pyridin-3- ylmethyl)pyrrolidine- 2-carboxamide::US9598446, Compound 43::US10660876, Cmpd No. 43	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303038	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303038&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322546	381751773							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580349	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ncc(Br)cn2)c2ccc(Nc3cncnc3)cc12 |r,$;;;;;;;;;;;;;;;;;;;;;;;;;;;;;HN;;;;;;;;$|	InChI=1S/C25H22BrFN8O3/c1-14(36)20-11-34(21-3-2-17(5-19(20)21)32-18-8-28-13-29-9-18)12-23(37)35-10-16(27)4-22(35)24(38)33-25-30-6-15(26)7-31-25/h2-3,5-9,11,13,16,22,32H,4,10,12H2,1H3,(H,30,31,33,38)	ABCAOIQEZPMKEC-UHFFFAOYSA-N	303039	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(5- bromopyrimidin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 44::US10660876, Cmpd No. 44	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303039	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303039&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322550	381751774							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580350	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(OCc3ccccc3)cn2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C33H30FN7O4/c1-21(42)28-17-40(29-9-7-24(12-27(28)29)38-25-13-35-20-36-14-25)18-32(43)41-16-23(34)11-30(41)33(44)39-31-10-8-26(15-37-31)45-19-22-5-3-2-4-6-22/h2-10,12-15,17,20,23,30,38H,11,16,18-19H2,1H3,(H,37,39,44)	XHXIBPYJNOCISF-UHFFFAOYSA-N	303040	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(5- (benzyloxy)pyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 45::US10660876, Cmpd No. 45	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303040	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303040&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322648	381751775							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580351	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3ccccc3c2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C31H27FN6O3/c1-19(39)27-16-37(28-9-8-24(12-26(27)28)35-25-13-33-18-34-14-25)17-30(40)38-15-22(32)11-29(38)31(41)36-23-7-6-20-4-2-3-5-21(20)10-23/h2-10,12-14,16,18,22,29,35H,11,15,17H2,1H3,(H,36,41)	KLMJCFJJNBKIJW-UHFFFAOYSA-N	303041	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (naphthalen-2- yl)pyrrolidine-2- carboxamide::US9598446, Compound 46::US10660876, Cmpd No. 46	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303041	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303041&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322569	381751776							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580352	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C25H22BrFN8O3/c1-14(36)19-11-34(20-3-2-16(5-18(19)20)31-17-6-29-13-30-7-17)12-24(37)35-10-15(27)4-21(35)25(38)33-23-9-28-8-22(26)32-23/h2-3,5-9,11,13,15,21,31H,4,10,12H2,1H3,(H,32,33,38)	VCVUUNVSBBEWQM-UHFFFAOYSA-N	303042	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(6- bromopyrazin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 47::US10660876, Cmpd No. 47	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303042	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303042&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322518	381751777							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580353	CC(=O)c1cn(CC(=O)C2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)c2C(F)(F)F)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C29H24ClF4N5O3/c1-15(40)22-12-39(25-6-5-17(9-19(22)25)37-18-10-35-14-36-11-18)13-26(41)20-7-16(31)8-21(20)28(42)38-24-4-2-3-23(30)27(24)29(32,33)34/h2-6,9-12,14,16,20-21,37H,7-8,13H2,1H3,(H,38,42)	UBOLKVOELQWTKE-UHFFFAOYSA-N	303043	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(3- chloro-2- (trifluoromethyl)- phenyl)- 4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 48	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303043	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303043&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118333557	381751778							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580354	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(cs2)-c2c(C)nc3sccn23)c2ccc(Nc3cncnc3)cc12 |r,$;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;HN;;;;;;;;$|	InChI=1S/C30H26FN9O3S2/c1-16-27(39-5-6-44-30(39)34-16)23-14-45-29(36-23)37-28(43)25-7-18(31)11-40(25)26(42)13-38-12-22(17(2)41)21-8-19(3-4-24(21)38)35-20-9-32-15-33-10-20/h3-6,8-10,12,14-15,18,25,35H,7,11,13H2,1-2H3,(H,36,37,43)	LYDIHGLPZDDVFY-UHFFFAOYSA-N	303044	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (4-(6- methylimidazo[2,1- b]thiazol-5-yl)thiazol- 2-yl)pyrrolidine-2- carboxamide::US9598446, Compound 49::US10660876, Cmpd No. 49	Complement factor D	Human		 5500							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303044	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303044&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322521	381751779							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580355	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(cs2)-c2ccc3CCCCc3c2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C34H32FN7O3S/c1-20(43)28-16-41(30-9-8-25(12-27(28)30)38-26-13-36-19-37-14-26)17-32(44)42-15-24(35)11-31(42)33(45)40-34-39-29(18-46-34)23-7-6-21-4-2-3-5-22(21)10-23/h6-10,12-14,16,18-19,24,31,38H,2-5,11,15,17H2,1H3,(H,39,40,45)	BDZNPMGIMUEEPO-UHFFFAOYSA-N	303045	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (4-(5,6,7,8- tetrahydronaphthalen- 2-yl)thiazol-2- yl)pyrrolidine-2- carboxamide::US9598446, Compound 50::US10660876, Cmpd No. 50	Complement factor D	Human		>10000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303045	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303045&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322639	381751780							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580356	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCc3c2c(F)ccc3F)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C30H27F3N6O3/c1-16(40)22-13-38(26-7-2-18(9-21(22)26)36-19-10-34-15-35-11-19)14-28(41)39-12-17(31)8-27(39)30(42)37-25-6-3-20-23(32)4-5-24(33)29(20)25/h2,4-5,7,9-11,13,15,17,25,27,36H,3,6,8,12,14H2,1H3,(H,37,42)	YHSCFRRYKWOEIC-UHFFFAOYSA-N	303046	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(4,7- difluoro-2,3-dihydro- 1H-inden-1-yl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 51::US10660876, Cmpd No. 51	Complement factor D	Human		 5500							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303046	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303046&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322631	381751781							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580357	CC(=O)c1cn(CC(=O)C2C[C@H](F)C[C@H]2C(=O)Nc2noc3cc(ccc23)C(F)(F)F)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C30H24F4N6O4/c1-15(41)24-12-40(25-5-3-18(9-21(24)25)37-19-10-35-14-36-11-19)13-26(42)22-7-17(31)8-23(22)29(43)38-28-20-4-2-16(30(32,33)34)6-27(20)44-39-28/h2-6,9-12,14,17,22-23,37H,7-8,13H2,1H3,(H,38,39,43)	XPGJUXYJQQFLPP-UHFFFAOYSA-N	303047	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (6- (trifluoromethyl)benzo [d]isoxazol-3- yl)pyrrolidine-2- carboxamide::US9598446, Compound 52	Complement factor D	Human		 5500							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303047	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303047&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118333558	381751782							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580358	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(CN)cc2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C28H28FN7O3/c1-17(37)24-14-35(25-7-6-21(9-23(24)25)33-22-11-31-16-32-12-22)15-27(38)36-13-19(29)8-26(36)28(39)34-20-4-2-18(10-30)3-5-20/h2-7,9,11-12,14,16,19,26,33H,8,10,13,15,30H2,1H3,(H,34,39)	NJCBKUZEBUKDAT-UHFFFAOYSA-N	303048	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(4- (aminomethyl)phenyl)- 4-fluoropyrrolidine- 2-carboxamide::US9598446, Compound 53::US10660876, Cmpd No. 53	Complement factor D	Human		 5500							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303048	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303048&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322574	381751783							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580359	COc1cc(C)cc2C(CCOc12)NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1cc(C(C)=O)c2cc(Nc3cncnc3)ccc12 |r|	InChI=1S/C32H33FN6O5/c1-18-8-24-26(6-7-44-31(24)29(9-18)43-3)37-32(42)28-10-20(33)14-39(28)30(41)16-38-15-25(19(2)40)23-11-21(4-5-27(23)38)36-22-12-34-17-35-13-22/h4-5,8-9,11-13,15,17,20,26,28,36H,6-7,10,14,16H2,1-3H3,(H,37,42)	GFKAGABXEDPLPZ-UHFFFAOYSA-N	303049	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (8-methoxy-6- methylchroman-4- yl)pyrrolidine-2- carboxamide::US9598446, Compound 54::US10660876, Cmpd No. 54	Complement factor D	Human		 5500							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303049	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303049&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322522	381751784							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580360	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2c[nH]nc2-c2ccc(Cl)cc2Cl)c2ccc(Nc3cncnc3)cc12 |r,$;;;;;;;;;;;;;;;;;;;;HN;;;;;;;;;;;;;;;;;;;;;;;$|	InChI=1S/C30H25Cl2FN8O3/c1-16(42)23-13-40(26-5-3-19(8-22(23)26)37-20-9-34-15-35-10-20)14-28(43)41-12-18(33)7-27(41)30(44)38-25-11-36-39-29(25)21-4-2-17(31)6-24(21)32/h2-6,8-11,13,15,18,27,37H,7,12,14H2,1H3,(H,36,39)(H,38,44)	AOTIYINPRJLNPH-UHFFFAOYSA-N	303050	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(3-(2,4- dichlorophenyl)-1H- pyrazol-4-yl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 55::US10660876, Cmpd No. 55	Complement factor D	Human		 5500							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303050	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303050&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322548	381751785							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580361	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3ncsc3c2)c2ccc(Nc3cncnc3)cc12 |r,$;;;;;;;;;;;;;;;;;HN;;;;;;;;;;;;;;;;;;;;;;$|	InChI=1S/C28H24FN7O3S/c1-16(37)22-12-35(24-5-3-18(7-21(22)24)33-20-9-30-14-31-10-20)13-27(38)36-11-17(29)6-25(36)28(39)34-19-2-4-23-26(8-19)40-15-32-23/h2-5,7-10,12,14-15,17,25,33H,6,11,13H2,1H3,(H,34,39)	ZHGHVKKSEKQRFQ-UHFFFAOYSA-N	303051	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N- (benzo[d]thiazol-6- yl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 56::US10660876, Cmpd No. 56	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303051	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303051&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322529	381751786							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580362	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(C)nn2-c2ccccc2F)c2ccc(Nc3cncnc3)cc12 |r,$;;;;;;;;;;;;;;;;;HN;;;;;;;;;;;;;;;;;;;;;;;;;;$|	InChI=1S/C31H28F2N8O3/c1-18-9-29(41(38-18)27-6-4-3-5-25(27)33)37-31(44)28-10-20(32)14-40(28)30(43)16-39-15-24(19(2)42)23-11-21(7-8-26(23)39)36-22-12-34-17-35-13-22/h3-9,11-13,15,17,20,28,36H,10,14,16H2,1-2H3,(H,37,44)	MGOSREJPXCVOFI-UHFFFAOYSA-N	303052	(2S,4R)-1-(2-(3-  acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (1-(2-fluorophenyl)-3- methyl-1H-pyrazol-5- yl)pyrrolidine-2- carboxamide::US9598446, Compound 57::US10660876, Cmpd No. 57	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303052	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303052&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322633	381751787							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580363	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCCN(C2=O)c2ccccc2Cl)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C32H31ClFN7O4/c1-19(42)24-16-39(27-9-8-21(12-23(24)27)37-22-13-35-18-36-14-22)17-30(43)41-15-20(34)11-29(41)31(44)38-26-6-4-10-40(32(26)45)28-7-3-2-5-25(28)33/h2-3,5,7-9,12-14,16,18,20,26,29,37H,4,6,10-11,15,17H2,1H3,(H,38,44)	UBXVSJSUZAETKL-UHFFFAOYSA-N	303053	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(1-(2- chlorophenyl)-2- oxopiperidin-3-yl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 58::US10660876, Cmpd No. 58	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303053	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303053&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322536	381751788							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580364	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2ccncc2)c2ccc(Nc3cncnc3)cc12 |r,$;;;;;;;;;;;;;;;;;HN;;;;;;;;;;;;;;;;;;;;$|	InChI=1S/C27H26FN7O3/c1-17(36)23-14-34(24-3-2-20(9-22(23)24)33-21-11-30-16-31-12-21)15-26(37)35-13-19(28)8-25(35)27(38)32-10-18-4-6-29-7-5-18/h2-7,9,11-12,14,16,19,25,33H,8,10,13,15H2,1H3,(H,32,38)	WGMMCCQIKZZOLO-UHFFFAOYSA-N	303054	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (pyridin-4- ylmethyl)pyrrolidine- 2-carboxamide::US9598446, Compound 59::US10660876, Cmpd No. 59	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303054	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303054&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322634	381751789							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580365	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(ns2)-c2cccc(Cl)c2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C29H24ClFN8O3S/c1-16(40)23-13-38(24-6-5-20(9-22(23)24)34-21-10-32-15-33-11-21)14-26(41)39-12-19(31)8-25(39)28(42)36-29-35-27(37-43-29)17-3-2-4-18(30)7-17/h2-7,9-11,13,15,19,25,34H,8,12,14H2,1H3,(H,35,36,37,42)	MQJLVLVDTJKBMP-UHFFFAOYSA-N	303055	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(3-(3- chlorophenyl)-1,2,4- thiadiazol-5-yl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 60::US10660876, Cmpd No. 60	Complement factor D	Human		>10000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303055	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303055&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322524	381751790							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580366	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccccc2-c2nncn2C)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C30H28FN9O3/c1-18(41)24-14-39(26-8-7-20(10-23(24)26)35-21-11-32-16-33-12-21)15-28(42)40-13-19(31)9-27(40)30(43)36-25-6-4-3-5-22(25)29-37-34-17-38(29)2/h3-8,10-12,14,16-17,19,27,35H,9,13,15H2,1-2H3,(H,36,43)	NQJQOGSCDFXIGA-UHFFFAOYSA-N	303056	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (2-(4-methyl-4H- 1,2,4-triazol-3- yl)phenyl)pyrrolidine- 2-carboxamide::US9598446, Compound 61::US10660876, Cmpd No. 61	Complement factor D	Human		>10000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303056	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303056&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322644	381751791							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580367	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2noc(n2)-c2ccccc2Cl)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C29H24ClFN8O4/c1-16(40)22-13-38(24-7-6-18(9-21(22)24)34-19-10-32-15-33-11-19)14-26(41)39-12-17(31)8-25(39)27(42)35-29-36-28(43-37-29)20-4-2-3-5-23(20)30/h2-7,9-11,13,15,17,25,34H,8,12,14H2,1H3,(H,35,37,42)	YBRRPQXZTADARY-UHFFFAOYSA-N	303057	(2S,4R)-1-(2-(3-  acetyl-5-(pyrimidin-5-  ylamino)-1H-indol-1- yl)acetyl)-N-(5-(2- chlorophenyl)-1,2,4- oxadiazol-3-yl)-4- fluoropyrrolidine-2- carboxamide::US9598446, Compound 62::US10660876, Cmpd No. 62	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303057	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303057&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322525	381751792							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580368	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCCN(C2=O)c2cc(C)ccc2F)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C33H33F2N7O4/c1-19-5-7-26(35)29(10-19)41-9-3-4-27(33(41)46)39-32(45)30-11-21(34)15-42(30)31(44)17-40-16-25(20(2)43)24-12-22(6-8-28(24)40)38-23-13-36-18-37-14-23/h5-8,10,12-14,16,18,21,27,30,38H,3-4,9,11,15,17H2,1-2H3,(H,39,45)	NCZJJJKTTOBGNN-UHFFFAOYSA-N	303058	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (1-(2-fluoro-5- methylphenyl)-2- oxopiperidin-3- yl)pyrrolidine-2- carboxamide::US9598446, Compound 63::US10660876, Cmpd No. 63	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303058	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303058&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322534	381751793							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580369	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCN(C2=O)c2ccn(C)n2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C29H30FN9O4/c1-17(40)22-14-37(24-4-3-19(10-21(22)24)33-20-11-31-16-32-12-20)15-27(41)39-13-18(30)9-25(39)28(42)34-23-5-8-38(29(23)43)26-6-7-36(2)35-26/h3-4,6-7,10-12,14,16,18,23,25,33H,5,8-9,13,15H2,1-2H3,(H,34,42)	CUJFHVUQADDZQW-UHFFFAOYSA-N	303059	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (1-(1-methyl-1H- pyrazol-3-yl)-2- oxopyrrolidin-3- yl)pyrrolidine-2- carboxamide::US9598446, Compound 64::US10660876, Cmpd No. 64	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303059	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303059&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322627	381751794							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
580370	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(O)n2)c2ccc(Nc3cncnc3)cc12 |r|	InChI=1S/C26H24FN7O4/c1-15(35)20-12-33(21-6-5-17(8-19(20)21)30-18-9-28-14-29-10-18)13-25(37)34-11-16(27)7-22(34)26(38)32-23-3-2-4-24(36)31-23/h2-6,8-10,12,14,16,22,30H,7,11,13H2,1H3,(H2,31,32,36,38)	YWZWNWRNFFGSJH-UHFFFAOYSA-N	303060	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (6-hydroxypyridin-2- yl)pyrrolidine-2- carboxamide::US9598446, Compound 68::US10660876, Cmpd No. 68	Complement factor D	Human		<1000							US Patent		10.7270/Q2ST7RWF		aid1796128	US9598446	Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	3/21/2017	3/29/2019	Achillion Pharmaceuticals	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303060	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303060&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322575	381751795							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	6QMT,6QMR,1FDP,6FUT,6FUJ,6FUI,6FUH,6FUG,6FTZ,6FTY,5NB6,5NAW,5NAT,5NAR,5MT4,5MT0,5FCK,5FBI,5FBE,8DEA,8D95,5NBA,5NB7,8DG6,6VMK,6VMJ,5TCC,5TCA,4D9R,1HFD,1DSU,1DIC,1DFP,1BIO	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4